Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
What Does Teva’s Exit From PhRMA Suggest About Its Priorities?
Teva Insists Its Memberships And Investments Must Be ‘Properly Seated’
Feb 07 2023
•
By
Dean Rudge
How will Teva approach its novel pipeline under Francis? • Source: Shutterstock
More from Strategy
More from Business